Loos, a professor at the University of Copenhagen and affiliated with a research center supported by the Novo Nordisk Foundation (the maker of Wegovy and Ozempic), noted, "The current model explains only 25% of the variability, and further research is needed to uncover the remaining 75%." However, she also expressed optimism, stating, "By combining genetic and clinical information, the era of personalized medicine, where we can select the best drug for each patient, may be upon us."
Natural alternatives such as dietary modifications and fiber supplements are generally much less expensive but require sustained behavioral changes and may be challenging to maintain long-term
In todays busy world, our skin is constantly exposed to pollution, stress, and unhealthy habits that can leave it looking dull and tired
Lombardo, F
Your body isn't adapted to this specific molecule respect the titration
These highly publicized lawsuits may open the door for other people harmed by Ozempic and similar drugs